Inactive Instrument

News Medivir AB (publ) OTC Markets

Equities

MVRBF

SE0020181014

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Transcript : Medivir AB, Q1 2024 Earnings Call, Apr 30, 2024	Apr. 30
MEDIVIR AB - INTERIM REPORT JANUARY - MARCH 2024	Apr. 30	AQ
Medivir AB Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 30	CI
Medivir brings the Q1 webcast forward to 10 a.m. on April 30	Apr. 29	AQ
Medivir to present data for the combination of fostrox + Lenvima in HCC at ESMO GI	Apr. 29	AQ
BioStock: Medivir optimizes study design after meeting FDA	Apr. 26	AQ
Medivir Gets Two US FDA Designations for MIV-711	Apr. 25	MT
Medivir : FDA grants Medivir´s MIV-711 Rare Pediatric Disease Designation and Orphan Drug Designation for the treatment of Legg-Calvé-Perthes Disease	Apr. 25	PU
FDA grants Medivir's MIV-711 Rare Pediatric Disease Designation and Orphan Drug Designation for the treatment of Legg-Calvé-Perthes Disease	Apr. 25	AQ
Medivir provides update from supportive Type C meeting with the FDA; preparations for enhanced phase 2b in HCC with fostrox + Lenvima continue	Apr. 23	AQ
BioStock: Medivir's partner makes clinical progress in veterinary project	Apr. 19	AQ
Medivir : The Board of Directors statement under Chapter 19 Section 22 of the Swedish Companies Act	Apr. 16	PU
Medivir's partner Vetbiolix announces positive results from Proof-of-Concept study with VBX-1000, previously known as MIV-701	Apr. 15	AQ
BioStock: Medivir continues to accelerate development with fostrox	Apr. 12	AQ
Medivir : The Nomination Committees proposal for the AGM	Apr. 09	PU
Medivir to present at Investing in Oncology Forum on April 10	Apr. 09	AQ
Medivir : Corporate Governance Report	Apr. 05	PU
Medivir 2023 Annual Report published	Apr. 04	AQ
Medivir : Notice of AGM 2024	Apr. 04	PU
Notice of Annual General Meeting of Medivir AB (publ)	Apr. 04	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Medivir AB (publ) OTC Markets

Equities

MVRBF

SE0020181014

Summary

Filters